Researchers have been excited about the medication , a groundbreaking dual treatment showing remarkable outcomes in clinical trials for size reduction . It acts by targeting two systems: GLP-1 and GIP, https://faypvrl765026.frewwebs.com/39981846/the-new-possibility-for-body-management